Dr. Deepak Koppaka

Dr. Deepak Koppaka

Verified
Consultant
  • Medical Oncologist
MBBS, MD, DM
Experience
12 yrs
AboutEducationAwardsSimilar doctorsFAQ

About Dr. Deepak Koppaka

  • Dr. Deepak Koppaka is a leading Medical Oncologist having 10 years of experience.
  • He completed his MBBS from G.S.L. Medical College, Rajahmundry, in 2011, MD in Radiation Oncology from the Postgraduate Institute of Medical Education and Research, Chandigarh, in 2014, and DM in Medical Oncology from Kidwai Cancer Institute, Bangalore, in 2018. 
  • He is also an expert in Chemotherapy and offers a variety of treatments like hormonal and biological therapies, immunotherapy, targeted therapy, etc.
  • He is trained in performing Central Line insertion, PICC insertion, Bone Marrow Aspiration, and Biopsy.
  • He is a well-known member of the Association Of Radiation Oncologists Of India, European Society For Medical Oncology, American Society Of Clinical Oncology, Indian Society Of Medical And Pediatric Oncology, and Indian Society Of Oncology.
  • He has numerous publications in national and international journals.
  • VerifiedMBBS, G.S.L. Medical College, Rajahmundary(2011)
  • VerifiedMD, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh(2014)
  • VerifiedDM, Kidwai Cancer Institute, Bangalore(2018)

Papers Published

  • Articles1. Koppaka D, Kapoor R, Bahl A, Bansal A, Mittal BR, Et Al. (2015) Impact Of Integrating Pet-Ct In Radiotherapy Planning Of Non-Small Cell Carcinoma Lung: Dosimetric And Radiobiological Comparison. J Integr Oncol 4:139. Doi:10.4172/2329-6771.1000139.
+ Read More
  • Abraham, Linu, A Rudresha, Smitha Saldanha, Deepak Koppaka, Lakshmaiah Kuntegowdanahalli, Lokanatha Dasappa, And Pretesh Kiran. 2016. 'Gemcitabine-Induced Supraventricular Tachycardia: A Rare Manifestation', Clinical Cancer Investigation Journal, 5: 200-02.
  • Haleshappa RA, Koppaka D, Thanky AH, Padma M, Amirtham U, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN. Genito-Urinary Malignancies In Patients With Disorders Of Sexual Development: An Experience From A Regional Cancer Center.
  • Rudresha, A. H., Abhishek Anand, K. C. Lakshmaiah, K. Govind Babu, D. Lokanatha, Amirtham Usha, Linu Abraham Jacob, Suresh Babu, K. N. Lokesh, L. K. Rajeev, And Deepak Koppaka. 2017. ‘Clinicopathological Profile And Treatment Outcome Of Squamous Cell Carcinoma Breast At A Tertiary Cancer Center In South India’, Memo – Magazine Of European Medical Oncology, 10: 259-62.
  • Lakshmaiah, K. C., A. Anand, K. G. Babu, L. Dasappa, L. A. Jacob, M. C. S. Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, And D. Koppaka. 2017. ‘Role Of Taxanes In Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center In South India’, World J Oncol, 8: 110-16. 6.Jacob, Linu, Abhishek Anand, Kuntegowdanahalli Lakshmaiah, Govind Babu, Dasappa Lokanatha, M Suresh Babu, Kadabur Lokesh, Antapura Rudresha, L Rajeev, And Deepak Koppaka. 2018. ‘Clinicopathological Profile And Treatment Outcomes Of Bilateral Breast Cancer: A Study From Tertiary Cancer Center In South India’, Indian Journal Of Medical And Paediatric Oncology, 39: 58-61.
  • Lokanatha, D., A. Anand, K. C. Lakshmaiah, K. Govind Babu, L. A. Jacob, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, D. Koppaka, And R. V. Kumar. 2017. ‘Primary Breast Angiosarcoma – A Single Institution Experience From A Tertiary Cancer Center In South India’, Breast Dis. 8.Kadabur, L., D. Koppaka, G. B. Kanakasetty, A. Usha, L. C. Kuntegowdanahalli, L. Dasappa, L. A. Jacob, S. Babu, R. A. Haleshappa, A. Abhishek, And L. K. Rajeev. 2017. ‘Dual Mutations And Complex Mutations In Metastatic Non-Small Cell Lung Cancer: A Single-Institution Experience From South India’, Indian J Cancer, 54: 228-30.
  • Lakshmaiah, K. C., Asati, V. , Babu, K. G., Lokanath, D. , Jacob, L. A., Babu, M. C., Lokesh, K. N., Rajeev, L. K., Rudresh, A. H., Saldanha, S., Koppaka, D. , Patidar, R. And Premalata, C. S. (2018), Role Of Prephase Treatment Prior To Definitive Chemotherapy In Patients With Diffuse Large B‐Cell Lymphoma. Eur J Haematol. 10.Govind Babu K, Anand Abhishek, Lakshmaiah Kuntegowdanahalli C, Lokanatha Dasappa, Jacob Linu Abraham, Babu MC Suresh, Lokesh Kadabur N, Rudresha Haleshappa A, Rajeev Lakkavalli K, Saldanha Smitha C, Giri GV, Chethan R, Koppaka Deepak, Panwar Dipti And Kumar Rekha V (2018) Correlation Of BMI With Breast Cancer Subtype And Tumour Size. Ecancer 12 845. 11.Lokesh KN, Anand A, Lakshmaiah KC, Babu KG, Lokanatha D, Jacob LA, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, D. Panwar, D. Koppaka, R. Patidar. Clinical Profile And Treatment Outcomes Of Metastatic Neuroendocrine Carcinoma: A Single Institution Experience. South Asian J Cancer 2018;7:207-9. 12.Haleshappa RA, Koppaka D, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN. Pattern Of Malignancies In Patients With HIV-AIDS: A Single Institution Observational Study. JCSO 2018;16(4):E188-E192.©2018 Frontline Medical Communications. Doi: Https://Doi.Org/10.12788/Jcso.0416. 13.15. Babu KG, Patidar R, Kuntegowdanahalli CL, Dasappa L, Jacob LA, Babu S, AH Rudresha, KN Lokesh, LK Rajeev, Koppaka D, Asati V. Metastatic Synovial Sarcoma: Experience From A Tertiary Care Center From India. Indian J Med Paediatr Oncol 2018;XX:XX-XX. 14.Jacob LA, Asati V, Lakshmaiah KC, Govind B, Lokanatha D, Babu S, Lokesh KN, Rudresh AH, Rajeev LK, Mulchandani JN, Anand A, Koppaka D, Suma MN. Primary Cutaneous B-Cell Lymphoma: A Single-Center 5-Year Experience. Indian J Cancer 2017;XX:XX-XX. DOI: 10.4103/Ijc.IJC_418_17. 15.16. Kanakasetty, G.B., Chethan, R., Lakshmaiah, K.C., Dasappa, L., Jacob, L.A., Babu, S., Lokesh, K.N., Haleshappa, R.A., Rajeev, L.K., Saldanha, S.C. And Deepak, K., 2019. Treatment Patterns And Comparative Analysis Of Non-Intensive Regimens In Elderly Acute Myeloid Leukemia Patients—A Real-World Experience From India. Annals Of Hematology, 98(4), Pp.881-888. 16.17. Balakrishnan, A., Koppaka, D., Anand, A., Deb, B., Grenci, G., Viasnoff, V., Thompson, E.W., Gowda, H., Bhat, R., Rangarajan, A. And Thiery, J.P., 2019. Circulating Tumor Cell Cluster Phenotype Allows Monitoring Response To Treatment And Predicts Survival. Scientific Reports, 9(1), P.7933. 17.18. Babu KG, D. Koppaka, Lokanatha D, Jacob LA, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, Anand A , Vikas A, Chethan R , Vedam L. Detection Of Clinically Relevant Epidermal Growth Factor Receptor Pathway Mutations In Circulating Cell-Free Tumour DNA Using Next Generation Sequencing In Squamous Cell Carcinoma Lung. South Asian J Cancer 2018 18.Ali MA, Babaiah M, Mariappan P, Sinha S, Muralidhar KR, Ponaganti S, Shah PA, Vuba SP, Gorla AKR, Koppaka D. A Rare Case Of Recurrent Paget’s Disease Of The Vulva And Gluteal Region Treated With Radiation Therapy. Appl Rad Oncol. 2020;9(1):44-47 19.II. Abstracts 20.1. Jotwani AK, Jain R, Sharma V, Goud RS, Haranath R, Koppaka D, Mishra A, Komanduri SK, Chilukuri RP, Sangwan H. Development Of" Online Cancer Patient Assistance Pathway"(OCPAP) Technology Platform To Provide Treatment Guidance For Cancer Patients In Developing Countries. 21.2. BABU G, KC L, JACOB AL, KN L, AH R, LK R, Koppaka D, Asati V, Patidar R. REAL WORLD COMPARISON OF THE TWO HYPOMETHYLATING AGENTS IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS-SINGLE INSTITUTION EXPERIENCE FROM INDIA: PB1752. HemaSphere. 2019 Jun 1;3:805. 22.3. Rajegowda C, BABU G, KC L, JACOB AL, KN L, AH R, LK R, Koppaka D, Asati V, Patidar R. CXCR-4 EXPRESSION AND ITS PROGNOSTIC IMPACT IN DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS-SINGLE INSTITUTION EXPERIENCE FROM SOUTH INDIA: PB1704. HemaSphere. 2019 Jun 1;3:785. 23.4. Koppaka D, Kuntegowdanahalli LC, Lokanath D, Govind Babu K, Jacob LA, Suresh Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Smitha SC, Anand A. 421O Assessment And Comparison Of CISNE Model Versus MASCC Model In Clinically Stable Febrile Neutropenia Patients. Annals Of Oncology. 2018 Nov 1;29(Suppl_9):Mdy444-001. 24.5. Babu G, Deepak K, Balakrishnan B, Biswas M, Prasath A, Radhakrishnan P, Chatterjee A, Thiyagarajan S, Chaudhuri P, Majumder PK. 1838P CANscript™ As A Patient-Derived Predictive Platform For Individualizing Treatment In Lung Cancer. Annals Of Oncology. 2018 Oct 1;29(Suppl_8):Mdy303-008. 25.5. Babu G, Deepak K, Balakrishnan B, Biswas M, Prasath A, Radhakrishnan P, Chatterjee A, Thiyagarajan S, Chaudhuri P, Majumder PK. 1838P CANscript™ As A Patient-Derived Predictive Platform For Individualizing Treatment In Lung Cancer. Annals Of Oncology. 2018 Oct 1;29(Suppl_8):Mdy303-008. 26.7. Babu G, Koppaka D, Vl R. P2. 01-125 EGFR Mutations By NGS In Advanced Squamous Cell Lung Cancer. Journal Of Thoracic Oncology. 2018 Oct 1;13(10):S713. 27.8. Koppaka D, Lakshmaiah KC, Babu KG, Dasappa L, Jacob LA, Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Saldanha SC. 246P Clinical Profile And Outcomes Of Carcinoma Anal Canal: A Single Institution Experience. Annals Of Oncology. 2017 Nov 1;28(Suppl_10):Mdx660-053.

Send Your Enquiry

Fill in your details and our medical experts will contact you within 24 hours.

By submitting I agree to the Terms of Use and Privacy Policy of Vaidam Health.

Want to consult the doctor?

Don't Ignore Your Health!

Other Top Medical Oncologist In Hyderabad

Dr. S.V.S.S Prasad

Dr. S.V.S.S Prasad

Medical Oncologist
Apollo Hospitals, Jubilee Hills Hyderabad · Hyderabad
42+ years of experience
Chat IconChat
Dr. Vijay Anand Reddy

Dr. Vijay Anand Reddy

5.0 (12 Ratings)
Medical Oncologist
Apollo Hospitals, Jubilee Hills Hyderabad · Hyderabad
32+ years of experience
Chat IconChat
Dr. A. V. S. Suresh

Dr. A. V. S. Suresh

5.0 (32 Ratings)
Medical Oncologist
Continental Hospitals, Hyderabad · Hyderabad
20+ years of experience
Chat IconChat

FAQ's About Dr. Deepak Koppaka

What is the specialty of Dr. Deepak Koppaka?

Dr. Deepak Koppaka specialty is Medical Oncologist

What is the experience of Dr. Deepak Koppaka?

Dr. Deepak Koppaka is Medical Oncologist with 12 years of experience.

Our Network

500+

Top Hospitals

10,000+

Doctors

50+

Cities

10+

Countries

Need Assistance?Chat